Thomas Gene Hooke, DPM | |
2500 Canyon Rd Ste 2, Bullhead City, AZ 86442-8624 | |
(928) 444-1491 | |
(928) 444-1330 |
Full Name | Thomas Gene Hooke |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 8 Years |
Location | 2500 Canyon Rd Ste 2, Bullhead City, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154784023 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213ES0103X | Podiatrist - Foot & Ankle Surgery | 5901002634 (Michigan) | Secondary |
213ES0103X | Podiatrist - Foot & Ankle Surgery | 000929 (Arizona) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Western Arizona Regional Medical Center | Bullhead city, AZ | Hospital |
Kingman Regional Medical Center | Kingman, AZ | Hospital |
Valley View Medical Center | Fort mohave, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Bullhead City Clinic Corp | 1052317575 | 25 |
News Archive
Women who have their first child before age 20 are at a higher risk of chronic diseases and death when they reach middle age, a new study shows.
A diet containing compounds found in green tea and carrots reversed Alzheimer's-like symptoms in mice genetically programmed to develop the disease, USC researchers say.
Georgia's kidney care community today praised the Georgia State Senate for unanimously passing important legislation (S.B. 316) to secure access to needed health insurance for approximately 2,000 Georgians suffering from kidney failure. The bill, which was originally introduced by Senators Don Thomas (R-Dalton) and Ed Harbison (D-Columbus), has received support from across the patient advocacy community and legislators alike.
Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that it has initiated a Phase 1 clinical study of HTL9936, the first fully selective muscarinic M1 receptor agonist to enter clinical development. HTL9936 is an orally available, small molecule drug candidate discovered using the Heptares GPCR structure-based drug design platform.
Heart failure affects roughly six million Americans, yet treatment consists of either a heart transplant or the insertion of mechanical devices that assist the heart. This is unacceptable to Roberto Bolli, MD, Chief of the Division of Cardiovascular Medicine at the University of Louisville in Louisville, Ky., which is why he is on a mission to make cardiac stem cell treatment an option for all who must cope with the limitations of a failing heart.
› Verified 1 days ago
Provider Name | Bullhead City Clinic Corp |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1962429878 PECOS PAC ID: 1052317575 Enrollment ID: O20061005000614 |
News Archive
Women who have their first child before age 20 are at a higher risk of chronic diseases and death when they reach middle age, a new study shows.
A diet containing compounds found in green tea and carrots reversed Alzheimer's-like symptoms in mice genetically programmed to develop the disease, USC researchers say.
Georgia's kidney care community today praised the Georgia State Senate for unanimously passing important legislation (S.B. 316) to secure access to needed health insurance for approximately 2,000 Georgians suffering from kidney failure. The bill, which was originally introduced by Senators Don Thomas (R-Dalton) and Ed Harbison (D-Columbus), has received support from across the patient advocacy community and legislators alike.
Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that it has initiated a Phase 1 clinical study of HTL9936, the first fully selective muscarinic M1 receptor agonist to enter clinical development. HTL9936 is an orally available, small molecule drug candidate discovered using the Heptares GPCR structure-based drug design platform.
Heart failure affects roughly six million Americans, yet treatment consists of either a heart transplant or the insertion of mechanical devices that assist the heart. This is unacceptable to Roberto Bolli, MD, Chief of the Division of Cardiovascular Medicine at the University of Louisville in Louisville, Ky., which is why he is on a mission to make cardiac stem cell treatment an option for all who must cope with the limitations of a failing heart.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Thomas Gene Hooke, DPM 2500 Canyon Rd Ste 2, Bullhead City, AZ 86442-8624 Ph: (928) 444-1491 | Thomas Gene Hooke, DPM 2500 Canyon Rd Ste 2, Bullhead City, AZ 86442-8624 Ph: (928) 444-1491 |
News Archive
Women who have their first child before age 20 are at a higher risk of chronic diseases and death when they reach middle age, a new study shows.
A diet containing compounds found in green tea and carrots reversed Alzheimer's-like symptoms in mice genetically programmed to develop the disease, USC researchers say.
Georgia's kidney care community today praised the Georgia State Senate for unanimously passing important legislation (S.B. 316) to secure access to needed health insurance for approximately 2,000 Georgians suffering from kidney failure. The bill, which was originally introduced by Senators Don Thomas (R-Dalton) and Ed Harbison (D-Columbus), has received support from across the patient advocacy community and legislators alike.
Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that it has initiated a Phase 1 clinical study of HTL9936, the first fully selective muscarinic M1 receptor agonist to enter clinical development. HTL9936 is an orally available, small molecule drug candidate discovered using the Heptares GPCR structure-based drug design platform.
Heart failure affects roughly six million Americans, yet treatment consists of either a heart transplant or the insertion of mechanical devices that assist the heart. This is unacceptable to Roberto Bolli, MD, Chief of the Division of Cardiovascular Medicine at the University of Louisville in Louisville, Ky., which is why he is on a mission to make cardiac stem cell treatment an option for all who must cope with the limitations of a failing heart.
› Verified 1 days ago
Palo Verde Foot & Ankle P L L C Podiatrist Medicare: Medicare Enrolled Practice Location: 3003 Highway 95 Ste 41, Bullhead City, AZ 86442 Phone: 928-758-3338 Fax: 928-758-4772 | |
Scott A Crampton, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3003 Highway 95 Ste 41, Bullhead City, AZ 86442 Phone: 928-758-3338 Fax: 928-758-4772 |